These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24486558)

  • 21. Investigation into the Effect of Ethylcellulose Viscosity Variation on the Drug Release of Metoprolol Tartrate and Acetaminophen Extended Release Multiparticulates-Part I.
    Mehta R; Teckoe J; Schoener C; Workentine S; Ferrizzi D; Rajabi-Siahboomi A
    AAPS PharmSciTech; 2016 Dec; 17(6):1366-1375. PubMed ID: 26743642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide.
    Quinten T; De Beer T; Almeida A; Vlassenbroeck J; Van Hoorebeke L; Remon JP; Vervaet C
    Drug Dev Ind Pharm; 2011 Feb; 37(2):149-59. PubMed ID: 20615154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations.
    Vervaeck A; Monteyne T; Saerens L; De Beer T; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2014 Oct; 88(2):472-82. PubMed ID: 25010389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous production of controlled release dosage forms based on hot-melt extruded gum arabic: Formulation development, in vitro characterization and evaluation of potential application fields.
    Kipping T; Rein H
    Int J Pharm; 2016 Jan; 497(1-2):36-53. PubMed ID: 26617317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.
    Vo AQ; Feng X; Pimparade M; Ye X; Kim DW; Martin ST; Repka MA
    Eur J Pharm Sci; 2017 May; 102():71-84. PubMed ID: 28257881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
    Ozgüney I; Shuwisitkul D; Bodmeier R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion.
    Almeida A; Possemiers S; Boone MN; De Beer T; Quinten T; Van Hoorebeke L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2011 Feb; 77(2):297-305. PubMed ID: 21168487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatty acids for controlled release applications: A comparison between prilling and solid lipid extrusion as manufacturing techniques.
    Vervaeck A; Monteyne T; Siepmann F; Boone MN; Van Hoorebeke L; De Beer T; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):173-84. PubMed ID: 26428938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upscaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations.
    Almeida A; Saerens L; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Dec; 439(1-2):223-9. PubMed ID: 23018111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hot-melt extrusion--basic principles and pharmaceutical applications.
    Lang B; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1133-55. PubMed ID: 24520867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new method for the continuous production of single dosed controlled release matrix systems based on hot-melt extruded starch: analysis of relevant process parameters and implementation of an in-process control.
    Kipping T; Rein H
    Eur J Pharm Biopharm; 2013 May; 84(1):156-71. PubMed ID: 23313175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between the permeability of metoprolol tartrate through plasticized isolated ethylcellulose/hydroxypropyl methylcellulose films and drug release from reservoir pellets.
    Ye ZW; Rombout P; Remon JP; Vervaet C; Van den Mooter G
    Eur J Pharm Biopharm; 2007 Sep; 67(2):485-90. PubMed ID: 17383166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hot-melt extrusion of polyvinyl alcohol for oral immediate release applications.
    De Jaeghere W; De Beer T; Van Bocxlaer J; Remon JP; Vervaet C
    Int J Pharm; 2015 Aug; 492(1-2):1-9. PubMed ID: 26160667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An innovative matrix controlling drug delivery produced by thermal treatment of DC tablets containing polycarbophil and ethylcellulose.
    Caviglioli G; Baldassari S; Cirrincione P; Russo E; Parodi B; Gatti P; Drava G
    Int J Pharm; 2013 Dec; 458(1):74-82. PubMed ID: 24144954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
    Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
    Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms.
    Vervaeck A; Saerens L; De Geest BG; De Beer T; Carleer R; Adriaensens P; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):587-96. PubMed ID: 23474381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel ethylcellulose-coated pellets for controlled release of metoprolol succinate without lag phase: characterization, optimization and in vivo evaluation.
    Wang Y; Yang J; Qian Y; Yang M; Qiu Y; Huang W; Shan L; Gao C
    Drug Dev Ind Pharm; 2015; 41(7):1120-9. PubMed ID: 24980911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.